Age-related macular degeneration

Giuseppe Querques, Fernando Onofrio Avellis, Lea Querques, Francesco Bandello, Eric H. Souied

Research output: Contribution to journalArticle

Abstract

Clinical question: Is there any new knowledge about the pathogenesis and treatment of age-related macular degeneration (AMD)? Results: We now understand better the biochemical and pathological pathways involved in the genesis of AMD. Treatment of exudative AMD is based on intravitreal injection of new antivascular endothelial growth factor drugs for which there does not yet exist a unique recognized strategy of administration. No therapies are actually available for atrophic AMD, despite some experimental new pharmacological approaches. Implementation: strategy of administration, safety of intravitreal injection.

Original languageEnglish
Pages (from-to)593-601
Number of pages9
JournalClinical Ophthalmology
Volume5
Issue number1
DOIs
Publication statusPublished - 2011

Keywords

  • Age-related macular degeneration
  • Antivascular endothelial growth factor
  • Choroidal neovascularization
  • Drusen
  • Geographic atrophy

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Age-related macular degeneration'. Together they form a unique fingerprint.

  • Cite this

    Querques, G., Avellis, F. O., Querques, L., Bandello, F., & Souied, E. H. (2011). Age-related macular degeneration. Clinical Ophthalmology, 5(1), 593-601. https://doi.org/10.2147/OPTH.S10161